A double-blinded, randomised, three-period crossover euglycaemic clamp trial investigating the pharmacokinetics, glucodynamics and safety of BC222 human insulin, human insulin (Huminsulin Normal) and insulin lispro (Humalog) in subjects with type 1 diabetes
Latest Information Update: 07 Jun 2017
At a glance
- Drugs Insulin (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Adocia
- 05 Feb 2015 Results published in the Adocia Media Release.
- 05 Feb 2015 Primary endpoint has been met as reported in an Adocia media release. (Increase of recombinant human insulin bioavailability during the first hour for HinsBet as compared to Humulin. AUCIns(0-1h))
- 21 Jul 2014 New source identified and integrated (European Clinical Trials Database record: EudraCT2014-001432-11)